Resnick Joshua — SEC Form 4 filings
SEC reporting owner CIK 1690959. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-28 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) | Director | 3 | — | — | 4 |
| PepGen Inc. (PEPG) | Director | 3 | — | — | 3 |
| Sionna Therapeutics, Inc. (SION) | Director | 2 | — | — | 2 |
| Vor Biopharma Inc. (VOR) | Director | 2 | — | — | 2 |
| Aerovate Therapeutics, Inc. (AVTE) | Director | 1 | — | — | 1 |
Form 4 filings — Resnick Joshua
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | PepGen Inc. (PEPG) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Sionna Therapeutics, Inc. (SION) | Grant/award (A): 17,340 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Cidara Therapeutics, Inc. (CDTX) | Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 5,079 (derivative) | EDGAR |
| 2025-06-18 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 5,079 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Sionna Therapeutics, Inc. (SION) | Grant/award (A): 19,959 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | PepGen Inc. (PEPG) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 22,200 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | PepGen Inc. (PEPG) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1690959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →